Abstract
Prevalence of dietary complementary and alternative medicine (CAM) and consultation with a CAM practitioner was examined in a cross-sectional study of 75 AS patients. Seventy one of 75 (94.7%) study participants reported previous or current CAM use. Among these AS patients, 44 (72.1%) reported dietary CAM use and 27 (36.0%) were seeing a CAM practitioner at the time of study. Of 89 dietary CAM, 50 (56.4%) were perceived to be of slight or no benefit, and only 10 (11.2%) were initiated by a CAM practitioner. Compared with non-users, current dietary CAM users were more likely to be female (OR 6.5; 95% CI, 1.8–23.9). Patients attending a CAM practitioner were more likely to have university education (OR 5.7; 95% CI, 1.5–21.9) and higher BASDAI (OR 1.3; 95%CI, 1.0–1.7). Despite low rates of perceived benefit, dietary CAM use and CAM practitioner attendance is common among AS patients.
This is a preview of subscription content, log in via an institution to check access.
References
Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379–1390
van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J et al (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54:2136–2146
Jois RN, Gaffney K, Keat A (2007) Anti-tumour necrosis factor therapy for ankylosing spondylitis-unresolved issues. Rheumatology 46:899–901
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275–2285
Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M (1999) Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 131:409–416
Cronan TA, Kaplan RM, Posner L, Blumberg E, Kozin F (1989) Prevalence of the use of unconventional remedies for arthritis in a metropolitan community. Arthritis Rheum 32:1604–1607
Buchbinder R, Gingold M, Hall S, Cohen M (2002) Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice. Intern Med J 32:208–214
Zochling J, March L, Lapsley H, Cross M, Tribe K, Brooks P (2004) Use of complementary medicines for osteoarthritis—a prospective study. Ann Rheum Dis 63:549–554
Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ (2004) Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis 1:A12
Cronan TA, Kaplan RM, Kozin F (1993) Factors affecting unprescribed remedy use among people with self-reported arthritis. Arthritis Care Res 6:149–155
Moore AD, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL et al (2000) The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis Rheum 43:1410–1418
Fautrel B, Adam V, St-Pierre Y, Joseph L, Clarke AE, Penrod JR (2002) Use of complementary and alternative therapies by patients self-reporting arthritis or rheumatism: results from a nationwide canadian survey. J Rheumatol 29:2435–2441
Haugen M, Kjeldsen-Kragh J, Nordvag BY, Forre O (1991) Diet and disease symptoms in rheumatic diseases—results of a questionnaire based survey. Clin Rheumatol 10:401–407
Ramos-Remus C, Watters CA, Dyke L, Suarez-Almazor ME, Russell AS (1999) Assessment of health locus of control in the use of nonconventional remedies by patients with rheumatic diseases. J Rheumatol 26:2468–2474
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285
Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ et al (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26
Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66–71
Australian bureau of statistics, Commonwealth of Australia. Socioeconomic indexes for areas (SEIFA) Volume 1.1. Australian bureau of statistics: Canberra, Australia, 2001
Feldman DE, Duffy C, De Civita M, Malleson P, Philibert L, Gibbon M et al (2004) Factors associated with the use of complementary and alternative medicines in juvenile idiopathic arthritis. Arthritis Rheum 51:527–532
MacLennan AH, Wilson DH, Taylor AW (1996) Prevalence and cost of alternative medicine in Australia. Lancet 347:569–573
Sundstrom B, Stalnacke K, Hagfors L, Johansson G (2006) Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis. Scand J Rheumatol 35:359–362
Vecchio PC (1994) Attitudes to alternative medicine by rheumatology outpatient attenders. J Rheumatol 21:145–147
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chatfield, S.M., Dharmage, S.C., Boers, A. et al. Complementary and alternative medicines in ankylosing spondylitis: a cross-sectional study. Clin Rheumatol 28, 213–217 (2009). https://doi.org/10.1007/s10067-008-1029-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-008-1029-3